Abstract
Gastrodigenin (HBA) and gastrodin (GAS) are phenolic ingredients found in Gastrodia elata Blume (GEB), a traditional Chinese herbal medicine. These compounds have been previously used to treat cognitive dysfunction, convulsion, and dizziness. However, at present, there is no available information regarding their potential ionic effects in electrically excitable cells. In the current study, the possible effects of HBA and GAS on different ionic currents in pituitary GH3 cells and hippocampal mHippoE-14 neurons were investigated using the patch-clamp technique. The addition of HBA or GAS resulted in the differential inhibition of the M-type K+ current (IK(M)) density in a concentration-dependent manner in GH3 cells. HBA resulted in a slowing of the activation time course of IK(M), while GAS elevated it. HBA also mildly suppressed the density of erg-mediated or the delayed-rectifier K+ current in GH3 cells. Neither GAS nor HBA (10 µM) modified the voltage-gated Na+ current density, although they suppressed the L-type Ca2+ current density at the same concentration. In hippocampal mHippoE-14 neurons, HBA was effective at inhibiting IK(M) density as well as slowing the activation time course. Taken together, the present study provided the first evidence that HBA or GAS could act on cellular mechanisms, and could therefore potentially have a functional influence in various neurologic disorders.
Keywords: gastrodigenin, p-hydroxybenzyl alcohol, gastrodin, M-type K+ current, L-type Ca2+ current and voltage-gated Na+ current
1. Introduction
Gastrodigenin (p-hydroxybenzyl alcohol, HBA) is a phenolic compound found in traditional Chinese herbal medicine Gastrodia elata Blume (GEB), which is commonly known as Tian Ma in Chinese or Chunma in Korean [1,2]. Gastrodin (GAS), the glucoside of HBA, is the major bioactive ingredient that can be isolated from GEB. In East Asian countries, the dried rhizomes of GEB have been widely used for centuries to treat many neurological or psychiatric disorders including convulsive disorders, dizziness, dementia, depression, and migraines [3]. Increasing research is being conducted to determine the underlying molecular mechanisms through which the active constituents of GEB may exert their pharmaceutical effects.
GAS has been demonstrated to penetrate the blood–brain barrier, and it has been suggested that it may produce neuroprotective effects against hypoxia, oxidative injuries, or glutamate induced excitotoxicity [4,5,6]. Recent studies have also provided evidence of its antiepileptic, anxiolytic, free-radical scavenging, anti-inflammatory, and anti-obesity actions [3,7]. After entering the central nervous system, GAS is metabolized to HBA [8]. HBA is an aglycone derivative of gastrodin. Some previous studies have addressed the potential promoting effects of HBA on cell proliferation and neuroblast differentiation in the dentate gyrus of mice [9]. In addition, HBA has been previously reported to improve learning and memory consolidation [10]. Despite strong evidence of their beneficial effects on various neurological disorders, HBA and GAS have so far been limited with respect to their effects on membrane ion currents in neurons and neuroendocrine cells.
The KCNQ2, KCNQ3, and KCNQ5 genes are known to encode for the core subunits of the KV7.2, KV7.3, and KV7.5 channels, respectively. Increased activity of these KV channels in neurons, or neuroendocrine or endocrine cells, can generate a unique population of the K+ current, named the M-type K+ current (IK(M)). This unique type of K+ current is characterized by its activation in response to a low threshold voltage and upon activation, it displays slowly activating and deactivating properties [11,12]. The subfamilies of the K+ channels regulate outward K+ current, maintain resting membrane potential, and control the neuronal firing threshold. Importantly, the targeting of IK(M) has been increasingly recognized as an adjunctive regimen for the treatment of different neurological disorders that are linked to neuronal excitability such as cognitive dysfunction, neuropathic pain, and epilepsy [13,14]. However, to the best of our knowledge, exactly how HBA or GAS exerts any effect on the amplitude and gating of this current has thus far been largely unexplored, despite HBA and GAS demonstrating a wide range of biological activities on the central nervous system in both in vivo and in vitro [3,4,5,6,7].
In light of the situation described above, the present study aimed to investigate the possible underlying mechanism of HBA or GAS action on different types of membrane ionic currents (e.g., IK(M), erg-mediated K+ current [IK(erg)], delayed-rectifier K+ current [IK(DR)], voltage-gated Na+ current [INa], and L-type Ca2+ current [ICa,L]) in two different types of electrically excitable central neurons, the pituitary GH3 cells and hippocampal mHippoE-14 neurons. Findings from the current study revealed that HBA and GAS can inhibit IK(M) in a concentration- and state-dependent manner in the tested cell types. These findings could lead to the further exploration of HBA and GAS pharmacological actions or other structurally similar phenolic compounds.
2. Results
2.1. Inhibitory Effect of HBA (Gastrodigenin) on IK(M) Density in GH3 Cells
In the initial set of experiments, the presence of IK(M) in the pituitary GH3 cells was examined to investigate whether HBA could exert any effects on the M-type K+ current. GH3 cells were bathed in a high-K+, Ca2+-free solution, and the recording pipette was filled with a K+-containing solution. Once the whole-cell mode was firmly achieved, the examined cells were maintained at −50 mV, and a depolarizing pulse of −10 mV with a duration of 1 s was subsequently applied to evoke a unique population of K+ currents, namely IK(M), as previously identified [15]. As depicted in Figure 1, the presence of HBA caused a progressive decrease in the density of IK(M) in these cells in a time- and concentration-dependent manner. For example, within 1 min of exposing the cells to 10 µM HBA, the IK(M) density when taken from −50 to −10 mV was significantly decreased from 11.5 ± 3.6 to 5.6 ± 0.9 pA/pF (n = 11, p < 0.05). After the agent was washed out, the current density returned to 11.2 ± 1.8 pA/pF (n = 10, p < 0.05). Concomitant with the decreased IK(M) density, the activation time course of IK(M) density elicited by membrane depolarization slowed down, while there was a progressive increase in the deactivation time course of the current density obtained upon repolarization following membrane depolarization to the holding potential (Figure 1B–D). The addition of HBA (10 µM) significantly increased the activation time constant (τact) of IK(M) density from 38.8 ± 4.3 to 46.8 ± 5.1 ms (n = 11, p < 0.05), while it concomitantly diminished the deactivation time constant (τdeact) of the current density from 43.2 ± 4.6 to 32.3 ± 3.4 ms (n = 11, p < 0.05).
2.2. Effect of GAS (Gastrodin) on IK(M) Density in GH3 Cells
The next series of experiments was designed to test if GAS, a phenolic glucoside that can be metabolized into HBA, could modify the density of IK(M) in pituitary GH3 cells. The profile of the experimental protocol used was similar to that used for the study of HBA on IK(M) density as described above. Notably, as GAS was applied, the density of IK(M) in response to membrane depolarization progressively decreased. However, along with the decreased current density, the τact and τdeact values of IK(M) density elicited by membrane depolarization were also reduced (Figure 2). For example, the addition of GAS (30 µM) significantly decreased the IK(M) density and τact to 2.2 ± 0.07 pA/pF and 17.9 ± 4.2 ms (n = 11, p < 0.05) from the control values of 3.8 ± 0.1 pA/pF and 44.6 ± 6.1 ms, respectively. In the continued presence of 30 µM GAS, the addition of flupirtine (10 µM), a known activator of IK(M) [16], attenuated the GAS-induced decrease in both the density and τact of IK(M), as seen in the GH3 cells.
2.3. Concentration-Dependent Inhibition of IK(M) Density Caused by the Presence of HBA or GAS
The effects of these agents on IK(M) in response to membrane depolarization were further examined and compared in the current study. The concentration-dependent association between the inhibitory effect of HBA or GAS on IK(M) as seen in the GH3 cells is illustrated in Figure 3. The IC50 values of HBA and GAS required for their effect on IK(M) amplitude, measured at the end of the depolarizing pulses, were calculated to be 12.1 and 19.4 µM, respectively. Inhibition of IK(M) by these compounds had Hill coefficients of 1.1, suggesting that one molecule interacts with a single channel tetramer. The suppressive effect of HBA on IK(M) observed in GH3 cells tended to be more potent than that of GAS.
2.4. Kinetic Study of HBA-induced Blocking of IK(M) Density in GH3 Cells
To provide a quantitative estimate for HBA-induced blocking of IK(M), the time constants for the relative blocking of deactivating IK(M) (i.e., (Icontrol-IHBA)/Icontrol) observed in these cells were further analyzed. Initially, the decaying time courses of relative blocking in the presence of different concentrations of HBA were fitted using a single-exponential function. The concentration dependence of IK(M) decay elicited by membrane depolarization is illustrated in Figure 4A,B. It is clear from these results that the presence of HBA produced a concentration-dependent increase in the rate constant (1/τ) of relative blocking. For example, as cells were depolarized from −50 to −10 mV for 1 s, the decaying time constants (τ) of the IK(M) relative block obtained in the presence of 10 and 30 µM were appropriately fitted with a single-exponential function with values of 18.5 ± 1.5 ms (n = 12) and 10.1 ± 1.2 ms (n = 11), respectively. Based on the first-order reaction scheme detailed in the Materials and Methods Section, the relationship between 1/τ and [B] was also found to be linear, with a correlation coefficient of 0.95 (Figure 4C). The blocking and unblocking rate constants for HBA-induced inhibition of IK(M) were thus estimated to be 0.00235 ms−1µM−1 and 0.028 ms−1, respectively; consequently, the value of the dissociation constant (KD = k-1/k+1*) turned out to be 11.9 µM, a value that is comparable with the IC50 value needed for HBA-mediated blocking of IK(M) as described above.
2.5. Effect of HBA-Induced Blocking of IK(M) Density Recorded from GH3 Cells
The effect of HBA on the IK(M) elicited in response to different pulses from a holding potential of −50 mV was further studied. In this set of experiments, cells were bathed in a high-K+, Ca2+-free solution, and the recording pipette was filled with a K+-containing solution. Once the whole-cell model was established, the depolarizing pulses from −50 mV to various potentials ranging between −50 and +10 mV were delivered to the cells. The current density–voltage relationship for the inhibition effect of HBA (10 µM) on IK(M) density is illustrated in Figure 5A, while the steady-state activation curve of IK(M) obtained with or without the addition of HBA (10 µM) is shown in Figure 5B. The activation curve obtained in the absence or presence of HBA was plotted against the test potential and least-squares fitted by the Boltzmann equation as detailed in the Materials and Methods Section. In the control (i.e., in the absence of HBA), V1/2 = −18.1 ± 0.8 mV and q = 4.1 ± 0.4 e (n = 11), whereas during cell exposure to HBA (10 µM), V1/2 = −8.9 ± 0.5 mV and q = 3.8 ± 0.4 e (n = 11). As such, the addition of HBA not only produced a reduction in IK(M) density, but also shifted the steady-state activation curve of the current in a rightward direction by approximately 9 mV. However, a minimal change in the estimated q value of the curve was detected during cell exposure to HBA, although the translocation of around 4 e across the electric field tends to be responsible for the voltage dependence of IK(M) activation in GH3 cells. Moreover, the reversal potential of IK(M) obtained in the absence and presence of 10 µM HBA did not differ (0 ± 2 mV (in the control) versus 0 ± 3 mV (in the presence of HBA), n = 7, p > 0.05). Consequently, the voltage-dependence of IK(M) in these cells was virtually modified in the presence of HBA; however, the movement through the electrical field in response to different membrane potentials did not differ. The voltage-dependent relation of HBA-induced blocking was further determined using the equation as detailed in the Materials and Methods Section [17]. The estimated values of Kd (i.e., the equilibrium constant at 0 mV) and δ (i.e., the relative electrical distance of the blocking site in the transmembrane electrical field from outside) required for the inhibitory effect on IK(M) were 11. 7 µM and 0.016, respectively (Figure 5C).
2.6. Effects of HBA on the Densities of IK(erg) and IK(DR) in GH3 Cells
The presence of HBA can modify the amplitude and gating of IK(M) observed in the GH3 cells. Whether other types of K+ currents (e.g., IK(erg) or IK(DR)) enriched in these cells could be perturbed by HBA was further investigated in the current study. In order to measure IK(erg) density, cells were bathed in high-K+, Ca2+-free solution, while to record the IK(DR) density, they were bathed in Ca2+-free Tyrode’s solution. The recording pipettes used in these experiments were filled with K+-containing solution. As shown in Figure 6A,B, the addition of HBA (10 µM) slightly suppressed the amplitude of deactivating IK(erg) density elicited by the entire voltage-clamp range. For example, as the examined cells were hyperpolarized from −10 to −100 mV, exposure to 10 µM HBA significantly decreased the IK(erg) density from 43.3 ± 11 to 34.2 ± 9 pA/pF (n = 11, p < 0.05), although at a concentration of 3 µM, it produced a minimal effect on IK(erg) density. Similarly, the IK(DR) elicited by membrane depolarization from −50 to +50 mV was mildly suppressed by HBA (10 µM) (Figure 6C,D). For example, as cells were exposed to 10 µM HBA, the IK(DR) density was significantly decreased to 36.7 ± 8.2 pA/pF from a control value of 45.8 ± 8.6 pA/pF (n = 11, p < 0.05); however, no evident change in the inactivation time course of IK(DR) in response to membrane depolarization was demonstrated in its presence. After washout of the agent, the current amplitude returned to 46.4 ± 8.1 pA/pF (n = 9, p < 0.05). Therefore, these results showed that the density of either IK(erg) or IK(DR) in GH3 cells appeared to be relatively resistant to suppression by HBA.
2.7. Suppressive Effect of HBA on ICa,L Density Recorded from GH3 Cells
It was further studied whether ICa,L density in GH3 cells could be modified during exposure to HBA. During these recordings, cells were bathed in normal Tyrode’s solution containing 1.8 mM CaCl2, 1 µM tetrodotoxin, and 10 mM tetraethylammonium chloride, and then the pipette was filled with a Cs+-containing solution. Tetrodotoxin is a potent blocker of INa, while tetraethylammonium chloride is a non-specific K+ current blocker. Once the whole-cell mode was firmly established, a membrane depolarization from −40 to 0 mV with a duration of 300 ms was delivered to evoke ICa,L in these cells. As shown in Figure 7, as cells were exposed to HBA, the peak amplitude of ICa,L was progressively decreased. For example, as a depolarizing pulse from −40 to 0 mV was applied, the addition of HBA (10 µM) markedly decreased the peak ICa,L density from 1.8 ± 0.06 to 0.6 ± 0.03 pA/pF (n = 12, p < 0.05). The density of Ca2+-activated nonselective cationic current obtained following the return of the depolarizing pulse to the holding potential [18] was also concomitantly reduced from 0.46 ± 0.03 to 0.41 ± 0.02 pA/pF (n = 12, p < 0.05). Similar observations regarding the effect on peak ICa,L were obtained in the presence of GAS (10 µM). After washout of the drug, the ICa,L amplitude was returned to 1.3 ± 0.04 pA/pF (n = 11, p < 0.05). Therefore, it is conceivable that HBA and GAS exert a depressive action on ICa,L density in GH3 cells.
2.8. Lack of HBA Effect on INa Density in GH3 Cells
Earlier reports have revealed that HBA or GAS might exert anti-epileptic actions [5,7]. Blocking of INa was reported to have a protective role in hypoxia-induced injury and neuronal cell death [19]. For these reasons, it was further examined whether these agents might elicit any modifications on the amplitude or gating of INa in electrically excitable cells (e.g., GH3 cells). In this set of experiments, the cells were bathed in Ca2+-free Tyrode’s solution containing 10 mM tetraethylammonium chloride and 1 µM CdCl2, and the pipette was filled with a Cs+-containing solution. As shown in Figure 8, when the cells were exposed to 30 µM HBA, the amplitude of INa was not modified (235 ± 12 pA/pF (control) versus 235 ± 12 pA/pF (in the presence of 30 µM HBA), n = 11, p > 0.05). Similar results were obtained in the presence of 30 µM GAS. However, in the continued presence of 30 µM HBA, the addition of 10 µM A-887826, an inhibitor of the NaV1.8 channel [20], was found to decrease the amplitude of INa density in GH3 cells, as evidenced by a significant reduction in peak INa to 173 ± 8 pA/pF (n = 11, p < 0.05). Moreover, the subsequent application of orthovanadate (10 µM) in the presence of HBA increased the peak INa to 282 ± 12 pA/pF (n = 11, p < 0.05); however, neither the activation nor the inactivation time course of INa were changed. Orthovanadate has been previously reported to enhance the peak amplitude of cardiac INa [21]. Therefore, rather than having an inhibitory effect on ICa,L density, neither HBA nor GAS was capable of altering the amplitude or gating of peak INa density, even though they were previously revealed to exert anti-epileptic actions.
2.9. Suppressive Effect of HBA on IK(M) Density in Hippocampal mHippoE-14 Neurons
Next, we tested whether IK(M) in central neurons (e.g., hippocampal neurons) could be influenced by HBA. Previous reports have demonstrated the presence of IK(M) density in the hippocampus [22]. The IK(M) density identified in the hippocampal mHippoE-14 neurons appeared to be smaller than that in the GH3 cells. As depicted in Figure 9, as cells were exposed to different HBA concentrations, the density of IK(M) was progressively decreased in response to the depolarizing pulse. Concomitant with this, a clear slowing in the activation time course of IK(M) density was also observed. Furthermore, in the continued presence of 10 µM HBA, the subsequent addition of ML-213 (10 µM), an activator of IK(M) [23], was effective at attenuating HBA-induced inhibition of IK(M) density. These experimental results therefore indicate that HBA-induced inhibition of IK(M) density tends to be indistinguishable from those described above in GH3 cells.
3. Discussion
In the current study, two structurally related phenolic compounds, HBA and GAS, were evaluated for their possible effects on different types of ionic currents in the pituitary cells and hippocampal neurons. The important findings of the current study were as follows: first, in pituitary GH3 lactotrophs, HBA, and GAS suppressed the density of IK(M) in a time- and concentration-dependent manner. Second, HBA-induced inhibition of IK(M) density was associated with a slowing of the activation time course of IK(M), while GAS-mediated inhibition was associated with the prolonging of the activation time course of the current. Third, HBA shifted the steady-state activation curve of IK(M) toward a depolarized potential with no change in the gating charge of the current. Fourth, this agent slightly suppressed the density of IK(erg) and IK(DR). Fifth, it inhibited the density of ICa,L, while no discernible change in peak INa density was detected in its presence. Sixth, in hippocampal mHippoE-14 neurons, the addition of HBA or GAS effectively inhibited the IK(M) density. Therefore, because GAS can penetrate through the blood–brain barrier, different types of ionic currents, particularly low-threshold IK(M) with slowly activating and deactivating properties, may be a relevant ‘target’ for the regulatory actions of these agents in neuroendocrine or central neurons, if similar in vivo findings occur.
The IC50 value of HBA or GAS needed to inhibit IK(M) as observed in the GH3 cells were estimated to be 12.1 and 19.4 µM, respectively; this indicates the higher potency of HBA on the suppression of IK(M). The peak concentrations of HBA in rat CSF and plasma after gastrodigenin (HBA) administration were previously reported to reach around 0.55 mg/mL (4.4 µM) and 0.47 (3.8 µM) µg/mL, respectively [24]. The present study also revealed the ability of this compound to shift the steady-state activation curve of IK(M) to a depolarized potential, despite no conceivable change in the gating charge of the curve in its presence. Additionally, voltage-dependent blocking by HBA of IK(M) with Kd (apparent affinity constant) or δ (fractional electrical distance) values of 11.7 µM and 0.016, respectively, were also further estimated in the current study. Therefore, it is important to point out that although the detailed ionic mechanisms of HBA action are still to be determined, modifications in the density and gating of IK(M) during its exposure, as presented in the current study, were rapid and sensitive to the preexisting resting potential, the concentrations achieved, or both [14].
Blocking of IK(M) density caused by HBA, not by GAS, does not tend to be instantaneous but instead develops over time after channels are opened upon abrupt membrane depolarization, which produces a significant decline in the slowly activating phase of the current (i.e., the activation time course). At the beginning, the depolarizing stimuli (i.e., dI/dt) are proportional to the number of channels available for activation. The trajectory of the IK(M) density in the presence of HBA was noted to display a prolonged activation that may be explained by the binding model, which indicates that the opening of channels was delayed by binding of the HBA molecule to the open states. The deactivating time course of IK(M) density in the presence of HBA or GAS also displayed a blunted peak together with increased decay, suggesting that the closing (i.e., deactivating process) of channels was considerably raised by unbinding of the HBA or GAS molecule.
In addition to the inhibition of IK(M) amplitude, a notable elevation in the dI/dt and τact values of IK(M) density were caused by the presence of GAS. These results imply that prior to channel activation, there might be a significant resting facilitation of the channel openness by GAS, but not by HBA. The effect of GAS on IK(M) density might also exist in the closed states. A possible explanation for such a discrepancy in the influence on the activation time course of IK(M) is that the sugar residue residing in the GAS molecule might facilitate the KM channel openness upon membrane depolarization. The addition of ouabain (10 µM), which is recognized to be a Na+-pump inhibitor containing a sugar residue, was also observed to suppress IK(M) density as well as enhance the value of τact in GH3 cells.
Intracellular zinc has been demonstrated to activate IK(M) through the decreased dependence on phosphatidylinositol 4,5-bisphosphate [25]. HBA was also recently reported to exert anti-zinc toxicity in astrocytes and neurons [26]. However, in the present study, further addition of zinc chloride (1 mM) in the presence of HBA or GAS was unable to attenuate their effective inhibition of IK(M) density in GH3 cells. The inhibitory effect of HBA or GAS on IK(M) density is unlikely to be associated with changes in the level of intracellular inositol triphosphate.
Distinguishable from the inability of HBA to modify the peak density of INa, the present results showed that the addition of HBA effectively suppressed the peak ICa,L density in GH3 cells, with no change in the overall I–V relationship of the current. The activity of ICa,L is well recognized to be enriched and functionally expressed in vascular smooth myocytes of different arteries including cerebral arteries. Therefore, to what extent HBA or GAS exerts beneficial effects on ischemic injuries in the brain [27,28] is connected, at least in part, through their inhibition of ICa,L density in excitable cells, warrants further investigation.
Minimal changes in the density or gating of INa in response to brief depolarizing pulses were observed in the presence of HBA or GAS. However, suppression by these agents of IK(M) density was able to depolarize the resting potential, thereby causing excitable cells to become hypo-excitable because of the resting inactivation of INa in these cells. Therefore, it is possible that the antiepileptic actions exerted by these agents can be attributed to other mechanisms such as GABAergic system enhancement and inhibition of glutamate induced excitotoxicity [29,30].
There have been conflicting opinions on the role played by HBA and GAS and their potential neuropharmacological effects, since HBA could also exert pharmacological effects on the central nervous system itself by binding with the benzodiazepine (or GABAA) receptor in brain membranes [31]. However, in the present study, further application of flumazenil (10 µM), still in the presence of GAS or HBA, did not attenuate the inhibitory actions on IK(M) density in GH3 cells. Flumazenil is known to be a benzodiazepine antagonist. The blocking of IK(M) by HBA and GAS seen in GH3 and mHippoE-14 cells is not highly associated with their propensity to interact with benzodiazepine receptors. However, whether the disparate action of HBA and GAS on the τact value of IK(M) density could be partly explained by their different neuropharmacological actions occurring in vivo, is worthy of further investigation. Moreover, based on the molecular mechanism reported herein, HBA and GAS may have potential as pharmacological probes that could be used for the characterization of KM or CaV channel properties as well as in therapeutic practice.
4. Materials and Methods
4.1. Drug and Solution Preparations
Gastrodin (GAS, gastrodine, p-hydroxymethylphenyl-β-D-glucopyranoside, 4-hydroxybenzyl alcohol-4-β-D-glucopyranoside, (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-(hydroxymethyl) phenoxy] oxane-3,4,5-triol, C13H18O7, PubChem CID: 115027), flumazenil, orthovanadate, ouabain, tetraethylammonium chloride, and tetrodotoxin were obtained from Sigma-Aldrich (St. Louis, MO, USA); gastrodigenin (p-hydroxybenzyl alcohol, 4-hydroxybenzyl alcohol, HBA) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA); and A-887826, flupirtine and ML-213 were obtained from Tocris Cookson (Bristol, UK). Unless stated otherwise, the culture media, L-glutamine, and trypsin were obtained from Invitrogen (Carlsbad, CA, USA). All other chemicals including CsCl, CdCl2, CsOH, and ZnCl2 were of the highest commercially available purity. The deionized water used throughout the experiments was made using a Milli-Q water purification system (APS Water Services, Inc., Van Nuys, CA, USA).
The composition of the bath solution (HEPES-buffered normal Tyrode’s solution) was 136 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.53 mM MgCl2, 5.5 mM glucose, and 5.5 mM HEPES-NaOH buffer, pH 7.4. To measure macroscopic K+ currents (e.g., IK(M), IK(erg), or IK(DR)) and preclude contamination of Cl- currents, the path pipettes were filled with a solution containing 130 mM K-aspartate, 20 mM KCl, 1 mM KH2PO4, 1 mM MgCl2, 3 mM Na2ATP, 0.1 mM Na2GTP, 0.1 mM EGTA, and 5 mM HEPES-KOH buffer, pH 7.2. For the recordings of whole-cell IK(M) or IK(erg), a high K+-bathing solution consisting of 145 mM KCl, 0.53 mM MgCl2, and 5 mM HEPES-KOH buffer, pH 7.4 was used, whereas the recording pipette was filled with a solution containing 145 mM KCl, 2 mM MgCl2, and 5 mM HEPES-KOH buffer, pH 7.2. To measure ICa,L or INa, the K+ ions inside the pipette solution were replaced with equimolar Cs+ ions, and the pH was then adjusted to 7.2 with CsOH. Each solution (e.g., the bath and pipette solutions) was filtered on the day of use with a disposable syringe filter with a 0.22 µm pore size (Millipore, Bedford, MA, USA).
4.2. Cell Preparations
GH3 pituitary tumor cells were obtained from the Bioresources Collection and Research Center ([BCRC-60015]; Hsinchu, Taiwan) and maintained in Ham’s F-12 medium supplemented with 15% horse serum (v/v), 2.5% fetal calf serum (v/v), and 2 mM L-glutamine in a humidified environment of 5% CO2/95% air. The embryonic mouse hippocampal cell line (mHippoE-14, CLU198) was obtained from Cedarlane CELLutions Biosystems, Inc. (Burlington, ON, Canada). Cells were grown in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum (v/v) and 2 mM L-glutamine [15]. The culture medium was changed every 2–3 days for the removal of non-adhering cells, and cells were passaged as they reached confluence.
4.3. Electrophysiological Measurements
Shortly before the experiments, the cells (i.e., GH3 cells and mHippoE-14 neurons) were dissociated, and an aliquot of cell suspension was transferred to a home-made recording chamber that was mounted on the stage of a DM-IL inverted microscope (Leica, Wetzlar, Germany), and then left to settle. The cells were immersed at room temperature (20–25 °C) in HEPES-buffered normal Tyrode’s solution, the composition of which is described above. For the recordings, patch electrodes were fabricated from borosilicate glass capillaries (#34500; Kimble Products, Vineland, NJ, USA) on a Narishige PP-830 puller (Narishige, Tokyo, Japan), then fire-polished with an MF-83 microforge (Narishige). The resistances existing between the standard pipette and the bathing solution ranged between 3 and 5 MΩ. Recordings of different types of ionic currents were measured in the whole-cell mode using the standard patch-clamp technique with either an RK-400 (Bio-Logic, Claix, France) or an Axopatch 200B patch-clamp amplifier (Molecular Devices, Sunnyvale, CA, USA) [32], which was interfaced via a Digidata 1440A to a PC running pCLAMP suite software (Molecular Devices). The liquid junction potentials were corrected shortly before seal formation was established.
4.4. Data Recording
The signals comprising both potential and current traces were stored online and sampled at 10 kHz using an ASUS VivoBook Flip-14 touchscreen laptop computer (TP412U; Taipei City, Taiwan), which was equipped with a Digidata 1440A interface (Molecular Devices) for analog-to-digital/digital-to-analog conversion. During the recordings, the latter device was driven by pCLAMP 10.7 software (Molecular Device) running on Windows 10 (Redmond, WA, USA), and the signals were simultaneously monitored on an MB169B+ monitor (ASUS, Taipei, Taiwan) through a USB type-C connection. When current signals were acquired, they were low-pass filtered at 2 kHz with a FL-4 four-pole Bessel filter (Dagan, Minneapolis, MN, USA) to minimize background noise. Through digital-to-analog conversion, various voltage-clamp profiles with either rectangular or ramp waveforms were created from pCLAMP and then applied to evaluate either the current versus voltage (I–V) relationship or the steady-state activation curve for the different types of ionic currents. As high-frequency stimuli needed to be delivered, an Astro-med Grass S88X dual output pulse stimulator was used (Grass Technologies, West Warwick, RI, USA). After the data were digitally collected, they were then analyzed using different analytical tools including the LabChart 7.0 program (AD Instruments, Castle Hill, Australia), 64-bit OriginPro 2016 (Microcal, Northampton, MA, USA), or custom-made macros built under Microsoft Excel 2013 (Redmond).
4.5. Concentration-Dependent Analyses of IK(M)
To evaluate the concentration-dependent effect of HBA or GAS on the amplitude of IK(M), GH3 cells were immersed in high-K+, Ca2+-free solution. Each examined cell was clamped at −50 mV and a 1-s depolarizing pulse from −50 to −10 mV was delivered. Current amplitudes at the end of the depolarizing pulse from −50 to −10 mV were measured in the control and during cell exposure to different concentrations (0.3–300 µM) of HBA or GAS. The concentration required to suppress 50% of the IK(M) amplitude was determined using a Hill function:
(1) |
where [C] represents the concentration of HBA or GAS; IC50 and nH are the concentration required for a 50% inhibition and the Hill coefficient, respectively; maximal inhibition (i.e., 1-a) was also estimated in this equation. This equation converged reliably to produce the best-fit line and parameter estimates as shown in Figure 3.
4.6. State-Dependent Analyses
The inhibitory effect of GAS or HBA on the IK(M) measured from pituitary GH3 cells may be explained by a state-dependent blocker that preferentially binds to the open state of the KM channel. A minimal kinetic scheme was postulated and derived as follows:
(2) |
where and are the voltage-gated rate constants for the opening and closing of K+ channels; k+1* and k-1 are the blocking and unblocking rate constants in the presence of HBA or GAS, respectively; C, O, and O B are the closed, open, and open-blocked states, respectively; and [B] is the HBA or GAS concentration applied. The blocking (i.e., on) and unblocking (i.e., off) rate constants, k+1* and k-1, were determined from the time constants (τ) of the depolarization-elicited relative block (i.e., (Icontrol-Icompound)/Icontrol) of deactivating IK(M) obtained in different concentrations of HBA or GAS. These rate constants were then computed according to the following relationship:
(3) |
where k+1* and k-1 are respectively derived from the slope and from the y-axis intercept at [B] = 0 of the linear regression interpolating the reciprocal time constants (1/τ) versus the HBA or GAS concentration, and [B] is the HBA or GAS concentration. Results from the blocker kinetic analysis are illustrated in Figure 4C.
4.7. Voltage-Dependent Analyses of HBA Effects on IK(M)
To determine the effect of HBA on the steady-state activation curve of IK(M) in GH3 cells, the cells were bathed in a high-K+, Ca2+-free solution. Once the whole-cell mode was established, the examined cells were maintained at −50 mV and voltage pulses were then applied from −50 mV to various test potentials up to +10 mV, with a duration of 1 s; these were delivered by the pCLAMP 10.7 program (Molecular Devices) through digital-to-analog conversion. The activation curve of the tail IK(M) obtained upon repolarization following each depolarizing pulse to the holding potential with or without the addition of HBA was appropriately fitted using the Boltzmann equation:
(4) |
where Imax is the maximal amplitude of deactivating IK(M); V is the membrane potential in mV; V1/2 the voltage at which there is half-maximal activation of the current; q is the apparent gating charge (i.e., the charge across the membrane electrical field between closed and open conformations); R is the universal gas constant; F is Faraday’s constant; T is the absolute temperature; and F/RT = 0.04 mV-1. To determine the voltage dependence, the HBA-induced block on IK(M) was assessed by fitting Equation (5) [17], taking the form:
(5) |
where f is the fractional block (i.e., 1 – IHBA/Icontrol); [B] is the HBA concentration; V is the membrane potential in mV; is the fractional electrical distance (i.e., the relative electrical distance of the blocking site in transmembrane electrical fields from outside); Kd is the affinity at the reference voltage (0 mV); and F, R and T are as described above.
4.8. Statistical Analyses
The linear or nonlinear (e.g., sigmoidal (dose-response or steady-state activation curve) or exponential functions) least-squares fitting procedures were implemented using either the Solver add-in bundled with Microsoft Excel 2013 (Redmond) or OriginPro 2016 (OriginLab, Northampton, MA, USA). The data are presented as the mean ± standard error of the mean (SEM) with sample sizes (n) indicating the number of cells from which the experimental results were collected. The error bars in all figures are plotted as SEM. A paired or unpaired Student’s t-test was used for the comparison of paired groups, and one-way analysis of variance (ANOVA) followed by a post-hoc Fisher’s least-significance difference test for multiple comparisons was implemented for the statistical evaluation of the differences between means. However, we used a non-parametric Kruskal–Wallis test if the assumption of normality underlying ANOVA could be violated. Statistical analyses were performed using IBM SPSS version 20.0 (IBM Corp., Armonk, NY, USA). A difference with a p value < 0.05 was considered to be statistically significant, unless otherwise stated.
5. Conclusions
Our present study provides the first electrophysiological evidence to indicate that HBA or GAS, the bioactive ingredients from GEB, exerted inhibitory actions on the M-type K+ current density in a concentration-dependent manner in pituitary GH3 cells. The presence of HBA also slightly suppressed the density of the erg-mediated or delayed-rectifier K+ current in GH3 cells. Apart from the K+ currents, HBA attenuated the density of the L-type Ca2+ current at the same concentration, although neither GAS nor HBA modified the voltage-gated Na+ current density. Moreover, in hippocampal mHippoE-14 neurons, HBA was effective at inhibiting IK(M) density as well as slowing the activation time course, which was similar to those findings observed in GH3 cells. The modulation of ionic current densities demonstrated by the present study conceivably represents a part of the fundamentally molecular mechanisms through which HBA and GAS can exert pharmacologic properties and functional influence in various neurologic disorders.
Acknowledgments
The authors would like to acknowledge the significant contribution that Kaisen Lee made to this work.
Abbreviations
CaV | Calcium channel |
GAS | Gastrodin |
GEB | Gastrodia elata Blume |
HBA | p-hydroxybenzyl alcohol |
I–V | Current versus voltage |
IC50 | The concentration required for 50% inhibition |
I Ca,L | L-type Ca2+ current |
I K(DR) | Delayed-rectifier K+ current |
I K(erg) | Erg-mediated K+ current |
I K(M) | M-type K+ current |
I Na | Voltage-gated Na+ current |
KM | M-type K+ channel |
KV | Potassium channel |
NaV | Sodium channel |
SEM | Standard error of mean |
τact | Activation time constant |
τdeact | Deactivation time constant |
Author Contributions
Conceptualization, C.-S.Y., C.-W.H., and S.-N.W.; Methodology, S.-N.W.; Validation, M.-C.L., C.-W.H. and S.-N.W.; Formal analysis, S.-N.W.; Investigation, S.-N.W.; Resources, P.-Y.L.; Data curation, Y.-C.L.; Writing–original draft preparation, C.-S.Y. and S.-N.W.; Writing: review and editing, C.-W.H. and S.-N.W.; Visualization, P.-Y.L.; Supervision, S.-N.W.; Project administration, C.-S.Y., C.-W.H., and S.-N.W.; Funding acquisition, C.-S.Y. and S.-N.W. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded in part by Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (grant number: TTCRD107-05 to C.-S.Y.) and the National Cheng Kung University (grant numbers: D106-35A13 and NCKUH-10709001 to S.-N.W.)
Conflicts of Interest
The authors declare no conflicts of interest.
References
- 1.Zhan H.D., Zhou H.Y., Sui Y.P., Du X.L., Wang W.H., Dai L., Sui F., Huo H.R., Jiang T.L. The rhizome of Gastrodia elata Blume—An ethnopharmacological review. J. Ethnopharmacol. 2016;189:361–385. doi: 10.1016/j.jep.2016.06.057. [DOI] [PubMed] [Google Scholar]
- 2.Tang C., Wu B., Wu J., Zhang Z., Yu B. Novel strategies using total gastrodin and gastrodigenin, or total gastrodigenin for quality control of Gastrodia elata. Molecules. 2018;23:270. doi: 10.3390/molecules23020270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Liu Y., Gao J., Peng M., Meng H., Ma H., Cai P., Xu Y., Zhao Q., Si G. A review on central nervous system effect of gastrodin. Front. Pharmacol. 2018;9:24. doi: 10.3389/fphar.2018.00024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Huang N.K., Chern Y., Fang J.M., Lin C.I., Chen W.P., Lin Y.L. Neuroprotective principles from Gastrodia elata. J. Nat. Prod. 2007;70:571–574. doi: 10.1021/np0605182. [DOI] [PubMed] [Google Scholar]
- 5.Jang J.H., Son Y., Kang S.S., Bae C.S., Kim J.C., Kim S.H., Shin T., Moon C. Neuropharmacological potential of Gastrodia elata Blume and its components. Evid. Based. Complement. Alternat. Med. 2015;2015:309261. doi: 10.1155/2015/309261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Wong S.B., Hung W.C., Min M.Y. The role of gastrodin on hippocampal neurons after N-methyl-D-aspartate excitotoxicity and experimental temporal lobe seizures. Chin. J. Physiol. 2016;59:156–164. doi: 10.4077/CJP.2016.BAE385. [DOI] [PubMed] [Google Scholar]
- 7.Ojemann L.M., Nelson W.L., Shin D.S., Rowe A.O., Buchanan R.A. Tian ma, an ancient Chinese herb, offers new options for the treatment of epilepsy and other conditions. Epilepsy Behav. 2006;8:376–383. doi: 10.1016/j.yebeh.2005.12.009. [DOI] [PubMed] [Google Scholar]
- 8.Lin L.C., Chen Y.F., Lee W.C., Wu Y.T., Tsai T.H. Pharmacokinetics of gastrodin and its metabolite p-hydroxybenzyl alcohol in rat blood, brain and bile by microdialysis coupled to LC-MS/MS. J. Pharm. Biomed. Anal. 2008;48:909–917. doi: 10.1016/j.jpba.2008.07.013. [DOI] [PubMed] [Google Scholar]
- 9.Cho J.H., Park J.H., Ahn J.H., Lee J.C., Hwang I.K., Park S.M., Ahn J.Y., Kim D.W., Cho J.H., Kim J.D., et al. Vanillin and 4-hydroxybenzyl alcohol promotes cell proliferation and neuroblast differentiation in the dentate gyrus of mice via the increase of brain-derived neurotrophic factor and tropomyosin-related kinase B. Mol. Med. Rep. 2016;13:2949–2956. doi: 10.3892/mmr.2016.4915. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hsieh M.T., Wu C.R., Chen C.F. Gastrodin and p-hydroxybenzyl alcohol facilitate memory consolidation and retrieval, but not acquisition, on the passive avoidance task in rats. J. Ethnopharmacol. 1997;56:45–54. doi: 10.1016/S0378-8741(96)01501-2. [DOI] [PubMed] [Google Scholar]
- 11.Brown B.S., Yu S.P. Modulation and genetic identification of the M channel. Prog. Biophys. Mol. Biol. 2000;73:135–166. doi: 10.1016/S0079-6107(00)00004-3. [DOI] [PubMed] [Google Scholar]
- 12.Lu T.L., Chang W.T., Chan C.H., Wu S.N. Evidence for effective multiple K+-current inhibitions by tolvaptan, a non-peptide antagonist of vasopressin V2 receptor. Front. Pharmacol. 2019;10:76. doi: 10.3389/fphar.2019.00076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Shu Y., Yu Y., Yang J., McCormick D.A. Selective control of cortical axonal spikes by a slowly inactivating K+ current. Proc. Natl. Acad. Sci. USA. 2007;104:11453–11458. doi: 10.1073/pnas.0702041104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Greene D.L., Hoshi N. Modulation of Kv7 channels and excitability in the brain. Cell. Mol. Life Sci. 2017;74:495–508. doi: 10.1007/s00018-016-2359-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.So E.C., Foo N.P., Ko S.Y., Wu S.N. Bisoprolol, known to be a selective β1-receptor antagonist, differentially but directly suppresses IK(M) and IK(erg) in pituitary cells and hippocampal neurons. Int. J. Mol. Sci. 2019;20:657. doi: 10.3390/ijms20030657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Wu S.N., Hsu M.C., Liao Y.K., Wu F.T., Jong Y.J., Lo Y.C. Evidence for inhibitory effects of flupirtine, a centrally acting analgesic, on delayed rectifier K+ currents in motor neuron-like cells. Evid. Based Complement. Alternat. Med. 2012;2012:148403. doi: 10.1155/2012/148403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Snyders D.J., Knoth K.M., Roberds S.L., Tamkun M.M. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel. Mol. Pharmacol. 1992;41:322–330. [PubMed] [Google Scholar]
- 18.Wu S.N., Li H.F., Jan C.R. Regulation of Ca2+-activated nonselective cationic currents in rat pituitary GH3 cells: Involvement in L-type Ca2+ current. Brain Res. 1998;812:133–141. doi: 10.1016/S0006-8993(98)00964-0. [DOI] [PubMed] [Google Scholar]
- 19.Xia Y., Fung M.L., O’Reilly J.P., Haddad G.G. Increased neuronal excitability after long-term O2 deprivation is mediated mainly by sodium channels. Mol. Brain Res. 2000;76:211–219. doi: 10.1016/S0169-328X(99)00338-1. [DOI] [PubMed] [Google Scholar]
- 20.Zhang X.F., Shieh C.C., Chapman M.L., Matulenko M.A., Hakeem A.H., Atkinson R.N., Kort M.E., Marron B.E., Joshi S., Honore P., et al. A-887826 is a structurally novel, potent and voltage-dependent NaV1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats. Neuropharmacology. 2010;59:201–207. doi: 10.1016/j.neuropharm.2010.05.009. [DOI] [PubMed] [Google Scholar]
- 21.Liu H., Sun H.Y., Lau C.P., Li G.R. Regulation of voltage-gated cardiac sodium current by epidermal growth factor receptor kinase in guinea pig ventricular myocytes. J. Mol. Cell. Cardiol. 2007;42:760–768. doi: 10.1016/j.yjmcc.2006.10.013. [DOI] [PubMed] [Google Scholar]
- 22.Hu B., Cilz N.I., Lei S. Somatostatin depresses the excitability of subicular bursting cells: Roles of inward rectifier K+ channels, KCNQ channels and Epac. Hippocampus. 2017;27:971–984. doi: 10.1002/hipo.22744. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Yu H., Wu M., Townsend S.D., Zou B., Long S., Daniels J.S., McManus O.B., Li M., Lindsley C.W., Hopkins C.R. Discovery, synthesis, and structure activity relationship of a series of N-aryl-bicyclo[2.2.1]heptane-2-carboxamides: Characterization of ML213 as a novel KCNQ2 and KCNQ4 potassium channel opener. ACS Chem. Neurosci. 2011;2:572–577. doi: 10.1021/cn200065b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wang Q., Chen G., Zeng S. Distribution and metabolism of gastrodin in rat brain. J. Pharm. Biomed. Anal. 2008;46:399–404. doi: 10.1016/j.jpba.2007.10.017. [DOI] [PubMed] [Google Scholar]
- 25.Gao H., Boillat A., Huang D., Liang C., Peers C., Gamper N. Intracellular zinc activates KCNQ channels by reducing their dependence on phosphatidylinositol 4,5-bisphosphate. Proc. Natl. Acad. Sci. USA. 2017;114:E6410–E6419. doi: 10.1073/pnas.1620598114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Luo L., Kim S.W., Lee H.K., Kim I.D., Lee H., Lee J.K. Anti-Zn2+-toxicity of 4-hydroxybenzyl alcohol in astrocytes and neurons contribute to a robust neuroprotective effects in the postischemic brain. Cell. Mol. Neurobiol. 2018;38:615–626. doi: 10.1007/s10571-017-0508-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Yu S.S., Zhao J., Zheng W.P., Zhao Y. Neuroprotective effect of 4-hydroxybenzyl alcohol against transient focal cerebral ischemia via anti-apoptosis in rats. Brain Res. 2010;1308:167–175. doi: 10.1016/j.brainres.2009.10.037. [DOI] [PubMed] [Google Scholar]
- 28.Kam K.Y., Yu S.J., Jeong N., Hong J.H., Jalin A.M., Lee S., Choi Y.W., Lee C.K., Kang S.G. p-Hydroxybenzyl alcohol prevents brain injury and behavioral impairment by activating Nrf2, PDI, and neurotrophic factor genes in a rat model of brain ischemia. Mol. Cells. 2011;31:209–215. doi: 10.1007/s10059-011-0028-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.An S.J., Park S.K., Hwang I.K., Choi S.Y., Kim S.K., Kwon O.S., Jung S.J., Baek N.I., Lee H.Y., Won M.H., et al. Gastrodin decreases immunoreactivities of gamma-aminobutyric acid shunt enzymes in the hippocampus of seizure-sensitive gerbils. J. Neurosci. Res. 2003;71:534–543. doi: 10.1002/jnr.10502. [DOI] [PubMed] [Google Scholar]
- 30.Jiang G., Wu H., Hu Y., Li J., Li Q. Gastrodin inhibits glutamate-induced apoptosis of PC12 cells via inhibition of CaMKII/ASK-1/p38 MAPK/p53 signaling cascade. Cell. Mol. Neurobiol. 2014;34:591–602. doi: 10.1007/s10571-014-0043-z. [DOI] [PubMed] [Google Scholar]
- 31.Jung J.W., Yoon B.H., Oh H.R., Ahn J.H., Kim S.Y., Park S.Y., Ryu J.H. Anxiolytic-like effects of Gastrodia elata and its phenolic constituents in mice. Biol. Pharm. Bull. 2006;29:261–265. doi: 10.1248/bpb.29.261. [DOI] [PubMed] [Google Scholar]
- 32.Wu S.N., Chern J.H., Shen S., Chen H.H., Hsu Y.T., Lee C.C., Chan M.H., Lai M.C., Shie F.S. Stimulatory actions of a novel thiourea derivative on large-conductance, calcium-activated potassium channels. J. Cell. Physiol. 2017;232:3409–3421. doi: 10.1002/jcp.25788. [DOI] [PubMed] [Google Scholar]